StocksDeepDive
Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

CTKB — Cytek Biosciences, Inc.

EXPENSIVE (MOS Model unreliable) · Quality 44/100

Value Score 30 days ago: 1.5 → today 3

Price
5.76
Intrinsic value
0.79
Margin of safety
Model unreliable
Implied growth (reverse DCF)
+39.0%
model assumes +1.8%
Value Score
3
Quality
44
Psychology
-2.4
Discovery
7.3
price/volume attention only
Moat score
6.2
erosion: none

Value Score: bottom 5% of Russell 3000 · Quality: bottom 31%

Open the interactive Deep Dive for CTKB →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/CTKB - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is CTKB undervalued?

As of 2026-11-11, CTKB trades at 5.76 against a computed intrinsic value of 0.79 (-629.1% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Cytek Biosciences, Inc.'s Value Score?

Cytek Biosciences, Inc.'s Value Score is 3 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.